Gold Standard
Regenerative
A clear, neutral explanation of Mexico's health regulator, how regenerative medicine is handled in Mexico compared with the United States, and what "investigational" and "not FDA-approved" actually mean for you as a patient.
COFEPRIS stands for the Comision Federal para la Proteccion contra Riesgos Sanitarios, Mexico's Federal Commission for Protection against Sanitary Risk. It is the government agency responsible for regulating medicines, medical devices, clinical establishments, and other health products and services in Mexico.
In its role within Mexico, COFEPRIS is broadly analogous to the U.S. Food and Drug Administration (FDA): both are national health authorities that license facilities and oversee safety. The important point is that COFEPRIS operates under Mexican law and Mexican standards, which are its own framework. It is a real regulator with real oversight, and it is distinct from the U.S. system.
When a clinic is described as COFEPRIS-licensed, it means the facility is authorized to operate under Mexican health regulations. Gold Standard Regenerative coordinates care with a COFEPRIS-licensed partner clinic, CMCells, in Ciudad Juarez, Mexico.
Different countries regulate cell therapies differently. Here is a factual comparison, with no judgment about either system.
The FDA regulates stem cell and cell-based products. Some uses are permitted, while many advanced regenerative protocols have not completed the FDA approval process. Therapies that have not been approved for a given use are generally not offered at U.S. clinics. The approval pathway is rigorous and exists to protect patients.
COFEPRIS licenses clinics and regulates health establishments under Mexican law. Within that framework, COFEPRIS-licensed clinics may offer certain regenerative protocols that are not available in the United States. These therapies are still considered investigational, and being available is not the same as being proven or FDA-approved.
These two phrases appear throughout regenerative medicine, and understanding them helps you make an informed decision.
Investigational means a therapy is still being studied and the evidence is preliminary. It is not a synonym for "proven." Research may be promising, but it is not yet settled, and responsible providers say so plainly.
Not FDA-approved means the U.S. FDA has not reviewed and approved the therapy for that specific use. It does not automatically mean a therapy is unsafe, and, just as importantly, approval or licensing in another country does not equal FDA approval. COFEPRIS licensing is not FDA approval. U.S. and Mexican standards differ, and patients should hold both facts at once: a Mexican clinic can be legitimately licensed by COFEPRIS while the therapy it offers remains investigational and not FDA-approved.
Whether you work with us or anyone else, these are reasonable questions every patient should ask before traveling for care.
A licensed clinic can confirm its COFEPRIS authorization to operate. It is reasonable to ask for this in writing.
Mexican physicians hold a Cedula Profesional (professional license). Confirm the treating physician's credentials and specialty.
Ask where cells come from, whether the source is a GMP-certified tissue bank, and how products are screened and tested.
A reputable clinic will document the protocol, what is included, and the known limits. Be cautious of anyone who will not.
COFEPRIS licensing provides regulatory oversight of clinics operating in Mexico, which is a meaningful protection. At the same time, traveling abroad for care has real limits that every patient should weigh honestly.
Legal recourse and consumer protections differ from country to country, and the avenues available to you in the United States may not apply in the same way abroad. Continuity of care and follow-up require planning across borders. And because these therapies are investigational, outcomes are not guaranteed. None of this means international care is wrong for you, it means the decision deserves clear eyes and good information.
That is the role Gold Standard Regenerative plays. As a U.S. medical-concierge service, we help patients understand their options, verify that care is delivered by COFEPRIS-licensed physicians in Mexico, and coordinate the logistics, while being candid about what regenerative medicine can and cannot promise.
COFEPRIS (Comision Federal para la Proteccion contra Riesgos Sanitarios) is Mexico's federal commission for protection against sanitary risk. It regulates medicines, medical devices, and health establishments in Mexico, a role broadly analogous to the U.S. FDA within Mexico's own legal framework.
No. COFEPRIS licensing applies under Mexican law and is not the same as U.S. FDA approval. A clinic being COFEPRIS-licensed does not mean a therapy is FDA-approved in the United States. U.S. and Mexican regulatory standards differ, and patients should understand that distinction clearly.
In the United States, stem cell products are regulated by the FDA. Some uses are permitted, while many advanced cell therapy protocols have not completed the FDA approval process and are therefore not offered at U.S. clinics. This is why some patients travel to COFEPRIS-licensed clinics in Mexico to explore investigational options.
Ask the clinic directly for its COFEPRIS registration, confirm the treating physician's Mexican professional license (Cedula Profesional), ask how cells are sourced and tested, and request documentation in writing. A reputable clinic will share this information.
Investigational means a therapy is still being studied and the evidence is preliminary. It is not the same as proven or approved. Patients should weigh investigational therapies carefully, with realistic expectations and a clear understanding of what is and is not yet established.
Medically reviewed by Dr. Karla Chavira, MD, Regenerative Medicine Physician and CEO of CMCells (Cédula Profesional on file).
Last reviewed: {{CONFIRM: review date}}
Our team can walk you through how care is regulated, how our partner clinic is licensed, and what to expect, so you can decide with confidence.
TALK WITH OUR TEAM →